Micropore Technologies Inc

Since 1958, Troxler Electronic Laboratories has been the worldwide leader in precision quality control and measurement equipment for the highway and construction industry. The company provides full-service, training and maintenance support for all of its products through its international sales and support offices in the U.S., Canada, Germany and through worldwide distributors. All Troxler products are tested to guarantee quality, dependability and performance and are backed by the industry s leading warranties.

Symbrium Inc is a leading engineering and software company based in Raleigh, NC, specializing in providing innovative solutions to difficult engineering challenges. With a focus on powertrain test systems, dimensional gauging, manufacturing process verification, custom gearboxes, and special measurement systems, Symbrium offers flexible, sustainable, and high-throughput solutions for the gear engineering community. With nearly four decades of experience, Symbrium is known for its collaborative approach to engineering, delivering results that matter. The company's culture of innovation and teamwork enables them to tackle complex projects and achieve standard-setting outcomes, making them a trusted partner for clients in industries such as precision manufacturing, powertrain engineering, turbo-machinery test laboratories, and military MRO.Generated from the website

AlphaVax Human Vaccines Inc., based in Durham, NC, is a privately-held clinical-stage biopharmaceutical company specializing in the development of innovative vaccines utilizing its proprietary RNA particle alphavaccine vector platform technology. The company focuses on anti-infective and anti-cancer vaccines, aiming to redefine their roles in medicine through a strategic approach that includes commercial partnerships for specific disease applications. With a portfolio of seven vaccine candidates targeting infectious diseases and cancer immunotherapy, AlphaVax has conducted multiple Phase 1 clinical trials. Its research highlights include encouraging results in cancer treatments, such as enhanced survival in patients with Stage IV colon cancer, showcasing the potential of its alphavaccine technology to engage the immune system effectively. Generated from the website